{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T22:29:48Z","timestamp":1769293788748,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-025-07711-5","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T05:53:10Z","timestamp":1766037190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The interplay between homocysteine, oxidative stress, and butyrylcholinesterase activity in the pathogenesis of schizophrenia"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5644-678X","authenticated-orcid":false,"given":"Manel","family":"Naifar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wassim","family":"Guidara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manel","family":"Maalej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalil","family":"Jmal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lobna","family":"Zouari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma Makni","family":"Ayadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"issue":"2","key":"7711_CR1","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/wps.21078","volume":"22","author":"A Abi-Dargham","year":"2023","unstructured":"Abi-Dargham A, Moeller SJ, Ali F, DeLorenzo C, Domschke K, Horga G, Jutla A, Kotov R, Paulus MP, Rubio JM, et al. Candidate biomarkers in psychiatric disorders: state of the field. World Psychiatry: Official J World Psychiatric Association (WPA). 2023;22(2):236\u201362.","journal-title":"World Psychiatry: Official J World Psychiatric Association (WPA)"},{"issue":"1","key":"7711_CR2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s10020-025-01258-7","volume":"31","author":"M Konjevod","year":"2025","unstructured":"Konjevod M, S\u00e1iz J, Bordoy L, Strac DS, Taha AY, Lanceros-M\u00e9ndez S, Alonso RM. Validated metabolomic biomarkers in psychiatric disorders: a narrative review. Mol Med (Cambridge Mass). 2025;31(1):254.","journal-title":"Mol Med (Cambridge Mass)"},{"issue":"1","key":"7711_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12881-015-0197-7","volume":"16","author":"S Numata","year":"2015","unstructured":"Numata S, Kinoshita M, Tajima A, Nishi A, Imoto I, Ohmori T. Evaluation of an association between plasma total homocysteine and schizophrenia by a Mendelian randomization analysis. BMC Med Genet. 2015;16(1):54.","journal-title":"BMC Med Genet"},{"issue":"1","key":"7711_CR4","first-page":"39","volume":"10","author":"K Tabata","year":"2024","unstructured":"Tabata K, Son S, Miyata J, Toriumi K, Miyashita M, Suzuki K, Itokawa M, Takahashi H, Murai T, Arai M. Association of homocysteine with white matter dysconnectivity in schizophrenia. Schizophrenia (Heidelberg Germany). 2024;10(1):39.","journal-title":"Schizophrenia (Heidelberg Germany)"},{"issue":"1","key":"7711_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12986-025-00933-0","volume":"22","author":"X Zhu","year":"2025","unstructured":"Zhu X, Wei J, Li J, Zuo S, Wang J, Liu N. The causal role of homocysteine in multiple diseases: a systematic review of Mendelian randomization studies. Nutr Metabolism. 2025;22(1):45.","journal-title":"Nutr Metabolism"},{"issue":"3","key":"7711_CR6","doi-asserted-by":"publisher","first-page":"867","DOI":"10.12669\/pjms.41.3.9999","volume":"41","author":"R An","year":"2025","unstructured":"An R, Zhang X, Luo X, Zhao Z, Zhen X. Relationship between cognitive impairment and oxidative stress markers in patients with early-onset schizophrenia. Pakistan J Med Sci. 2025;41(3):867\u201371.","journal-title":"Pakistan J Med Sci"},{"key":"7711_CR7","doi-asserted-by":"crossref","unstructured":"Plascencia-Villa G, Perry G. Roles of oxidative stress in synaptic dysfunction and neuronal cell death in Alzheimer\u2019s disease. Antioxid (Basel Switzerland). 2023;12(8).","DOI":"10.3390\/antiox12081628"},{"issue":"10","key":"7711_CR8","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.12669\/pjms.40.10.8923","volume":"40","author":"Y Xu","year":"2024","unstructured":"Xu Y, Qian X, Zhang M, Liang M. Correlations of cognitive function with serum levels of homocysteine, sex hormone binding globulin, and leptin in patients with schizophrenia. Pakistan J Med Sci. 2024;40(10):2319\u201323.","journal-title":"Pakistan J Med Sci"},{"key":"7711_CR9","doi-asserted-by":"crossref","unstructured":"Zhilyaeva TV, Piatoikina AS, Bavrina AP, Kostina OV, Zhukova ES, Shcherbatyuk TG, Blagonravova AS, Dubinina EE, Mazo GE. Homocysteine in Schizophrenia: Independent Pathogenetic Factor with Prooxidant Activity or Integral Marker of Other Biochemical Disturbances? Schizophrenia research and treatment. 2021; 2021:7721760.","DOI":"10.1155\/2021\/7721760"},{"issue":"1","key":"7711_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.schres.2013.05.028","volume":"150","author":"R Tandon","year":"2013","unstructured":"Tandon R, Gaebel W, Barch DM, Bustillo J, Gur RE, Heckers S, Malaspina D, Owen MJ, Schultz S, Tsuang M, et al. Definition and description of schizophrenia in the DSM-5. Schizophr Res. 2013;150(1):3\u201310.","journal-title":"Schizophr Res"},{"issue":"2\u20133","key":"7711_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","volume":"79","author":"S Leucht","year":"2005","unstructured":"Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel RR. What does the PANSS mean? Schizophr Res. 2005;79(2\u20133):231\u20138.","journal-title":"Schizophr Res"},{"key":"7711_CR12","doi-asserted-by":"publisher","first-page":"113467","DOI":"10.1016\/j.psychres.2020.113467","volume":"293","author":"W Guidara","year":"2020","unstructured":"Guidara W, Messedi M, Naifar M, Maalej M, Grayaa S, Omri S, Ben Thabet J, Maalej M, Charfi N, Ayadi F. Predictive value of oxidative stress biomarkers in drug\u2013free patients with schizophrenia and schizo-affective disorder. Psychiatry Res. 2020;293:113467.","journal-title":"Psychiatry Res"},{"key":"7711_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0076-6879(94)33041-7","volume":"233","author":"AZ Reznick","year":"1994","unstructured":"Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 1994;233:357\u201363.","journal-title":"Methods Enzymol"},{"issue":"5","key":"7711_CR14","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/ki.1996.186","volume":"49","author":"V Witko-Sarsat","year":"1996","unstructured":"Witko-Sarsat V, Friedlander M, Capeill\u00e8re-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49(5):1304\u201313.","journal-title":"Kidney Int"},{"issue":"3","key":"7711_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000136485","volume":"11","author":"DJ Jollow","year":"1974","unstructured":"Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology. 1974;11(3):151\u201369.","journal-title":"Pharmacology"},{"issue":"1","key":"7711_CR16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/0003-2697(68)90092-4","volume":"25","author":"J Sedlak","year":"1968","unstructured":"Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with ellman\u2019s reagent. Anal Biochem. 1968;25(1):192\u2013205.","journal-title":"Anal Biochem"},{"key":"7711_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","volume":"105","author":"H Aebi","year":"1984","unstructured":"Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121\u20136.","journal-title":"Methods Enzymol"},{"issue":"1","key":"7711_CR18","doi-asserted-by":"publisher","first-page":"45477","DOI":"10.1038\/srep45477","volume":"7","author":"S Mazzara","year":"2017","unstructured":"Mazzara S, Rossi RL, Grifantini R, Donizetti S, Abrignani S, Bombaci M. CombiROC: an interactive web tool for selecting accurate marker combinations of omics data. Sci Rep. 2017;7(1):45477.","journal-title":"Sci Rep"},{"issue":"12","key":"7711_CR19","first-page":"Ra214","volume":"13","author":"UN Das","year":"2007","unstructured":"Das UN. Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation. Med Sci Monitor: Int Med J Experimental Clin Res. 2007;13(12):Ra214\u2013221.","journal-title":"Med Sci Monitor: Int Med J Experimental Clin Res"},{"issue":"11","key":"7711_CR20","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1016\/j.neurobiolaging.2013.04.027","volume":"34","author":"T Darreh-Shori","year":"2013","unstructured":"Darreh-Shori T, Vijayaraghavan S, Aeinehband S, Piehl F, Lindblom RP, Nilsson B, Ekdahl KN, L\u00e5ngstr\u00f6m B, Almkvist O, Nordberg A. Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with alzheimer\u2019s disease. Neurobiol Aging. 2013;34(11):2465\u201381.","journal-title":"Neurobiol Aging"},{"issue":"12","key":"7711_CR21","doi-asserted-by":"publisher","first-page":"e050501","DOI":"10.1136\/bmjopen-2021-050501","volume":"11","author":"B Schick","year":"2021","unstructured":"Schick B, Barth E, Mayer B, Weber CL, Hagemeyer T, Sch\u00f6nfeldt C. Prospective, observational, single-centre cohort study with an independent control group matched for age and sex aimed at investigating the significance of cholinergic activity in patients with schizophrenia: study protocol of the CLASH-study. BMJ Open. 2021;11(12):e050501.","journal-title":"BMJ Open"},{"issue":"10","key":"7711_CR22","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/jamapsychiatry.2014.1332","volume":"71","author":"GM Khandaker","year":"2014","unstructured":"Khandaker GM, Pearson RM, Zammit S, Lewis G, Jones PB. Association of serum Interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry. 2014;71(10):1121\u20138.","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"7711_CR23","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1189\/jlb.0212100","volume":"92","author":"W Beumer","year":"2012","unstructured":"Beumer W, Gibney SM, Drexhage RC, Pont-Lezica L, Doorduin J, Klein HC, Steiner J, Connor TJ, Harkin A, Versnel MA, et al. The immune theory of psychiatric diseases: a key role for activated microglia and Circulating monocytes. J Leukoc Biol. 2012;92(5):959\u201375.","journal-title":"J Leukoc Biol"},{"issue":"6","key":"7711_CR24","first-page":"647","volume":"69","author":"M Hajer","year":"2011","unstructured":"Hajer M, Haithem M, Anouar M, Houda R, Wahiba D, Lotfi G, Mohamed Fadhel N. \u00c9tude de l\u2019activit\u00e9 butyrylcholinest\u00e9rase Chez des patients schizophr\u00e8nes. Ann Biol Clin. 2011;69(6):647\u201352.","journal-title":"Ann Biol Clin"},{"key":"7711_CR25","doi-asserted-by":"crossref","unstructured":"Gatta V, Mengod G, Reale M, Tata AM. Possible correlation between cholinergic system alterations and Neuro\/Inflammation in multiple sclerosis. Biomedicines. 2020;8(6).","DOI":"10.3390\/biomedicines8060153"},{"issue":"2","key":"7711_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1515\/revneuro-2019-0057","volume":"31","author":"T Berry","year":"2020","unstructured":"Berry T, Abohamza E, Moustafa AA. Treatment-resistant schizophrenia: focus on the transsulfuration pathway. Rev Neurosci. 2020;31(2):219\u201332.","journal-title":"Rev Neurosci"},{"key":"7711_CR27","doi-asserted-by":"publisher","first-page":"1380900","DOI":"10.3389\/fpsyt.2024.1380900","volume":"15","author":"N Fan","year":"2024","unstructured":"Fan N, Zhao W, Yun Y, Bai L, An H, Zhang Q, Yan J, Fan F, Han X, Yang F. Homocysteine levels in first-episode patients with psychiatric disorders. Front Psychiatry. 2024;15:1380900.","journal-title":"Front Psychiatry"},{"issue":"7","key":"7711_CR28","first-page":"664","volume":"65","author":"A Ezzaher","year":"2011","unstructured":"Ezzaher A, Mouhamed DH, Mechri A, Omezzine A, Neffati F, Douki W, Bouslama A, Gaha L, Najjar MF. Hyperhomocysteinemia in Tunisian bipolar I patients. J Neuropsychiatry Clin Neurosci. 2011;65(7):664\u201371.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"4","key":"7711_CR29","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.encep.2010.12.004","volume":"37","author":"H Mabrouk","year":"2011","unstructured":"Mabrouk H, Douki W, Mechri A, Younes MK, Omezzine A, Bouslama A, Gaha L, Najjar MF. [Hyperhomocysteinemia and schizophrenia: case control study]. L\u2019Encephale. 2011;37(4):308\u201313.","journal-title":"L\u2019Encephale"},{"key":"7711_CR30","doi-asserted-by":"crossref","unstructured":"Yan Y, Zhou D, Chen J. Navigating nutritional inequality in schizophrenia: a comprehensive exploration of diet, genetics, and holistic management across the life cycle. Nutrients. 2024;16(21).","DOI":"10.3390\/nu16213738"},{"key":"7711_CR31","doi-asserted-by":"publisher","first-page":"103503","DOI":"10.1016\/j.nicl.2023.103503","volume":"40","author":"F Detcheverry","year":"2023","unstructured":"Detcheverry F, Senthil S, Narayanan S, Badhwar A. Changes in levels of the antioxidant glutathione in brain and blood across the age span of healthy adults: A systematic review. NeuroImage: Clin. 2023;40:103503.","journal-title":"NeuroImage: Clin"},{"key":"7711_CR32","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.3390\/ijms22095010","volume":"22","author":"K Aoyama","year":"2021","unstructured":"Aoyama K. Glutathione in the brain. Int J Mol Sci. 2021;22:5010.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"7711_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12888-023-05479-0","volume":"24","author":"H Yang","year":"2024","unstructured":"Yang H, Zhang C, Yang M, Liu J, Zhang Y, Liu D, Zhang X. Variations of plasma oxidative stress levels in male patients with chronic schizophrenia. Correlations with psychopathology and matrix metalloproteinase-9: a case-control study. BMC Psychiatry. 2024;24(1):20.","journal-title":"BMC Psychiatry"},{"key":"7711_CR34","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.2147\/NDT.S385631","volume":"18","author":"O Hur\u015fito\u011flu","year":"2022","unstructured":"Hur\u015fito\u011flu O, Kurutas EB, Strawbridge R, Uygur OF, Yildiz E, Reilly TJ. Serum NOX1 and Raftlin as new potential biomarkers of interest in schizophrenia: A preliminary study. Neuropsychiatr Dis Treat. 2022;18:2519\u201327.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"7711_CR35","first-page":"4","volume":"11","author":"Z Peng","year":"2025","unstructured":"Peng Z, Jia Q, Mao J, Jiang S, Ma Q, Luo X, An Z, Huang A, Ma C, Yi Q. The role of ferroptosis and oxidative stress in cognitive deficits among chronic schizophrenia patients: a multicenter investigation. Schizophrenia (Heidelberg Germany). 2025;11(1):4.","journal-title":"Schizophrenia (Heidelberg Germany)"},{"issue":"3","key":"7711_CR36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/WNF.0000000000000594","volume":"47","author":"S Weng","year":"2024","unstructured":"Weng S, Zheng R, Lin R. Correlation of serum High-Sensitivity C-Reactive Protein, Homocysteine, and macrophage migration inhibitory factor levels with symptom severity and cognitive function in patients with schizophrenia. Clin Neuropharmacol. 2024;47(3):82\u20136.","journal-title":"Clin Neuropharmacol"},{"key":"7711_CR37","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.schres.2024.03.053","volume":"267","author":"H Li","year":"2024","unstructured":"Li H, Huang Y, Liang L, Li H, Li S, Feng Y, Feng S, Wu K, Wu F. The relationship between the gut microbiota and oxidative stress in the cognitive function of schizophrenia: A pilot study in China. Schizophr Res. 2024;267:444\u201350.","journal-title":"Schizophr Res"},{"issue":"4","key":"7711_CR38","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.biopsych.2013.09.037","volume":"75","author":"V Bergink","year":"2014","unstructured":"Bergink V, Gibney SM, Drexhage HA. Autoimmunity, inflammation, and psychosis: a search for peripheral markers. Biol Psychiatry. 2014;75(4):324\u201331.","journal-title":"Biol Psychiatry"},{"issue":"5","key":"7711_CR39","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/jamapsychiatry.2013.900","volume":"70","author":"JL Roffman","year":"2013","unstructured":"Roffman JL, Lamberti JS, Achtyes E, Macklin EA, Galendez GC, Raeke LH, Silverstein NJ, Smoller JW, Hill M, Goff DC. Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia. JAMA Psychiatry. 2013;70(5):481\u20139.","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"7711_CR40","first-page":"14","volume":"81","author":"World Medical Association Declaration of Helsinki","year":"2014","unstructured":"World Medical Association Declaration of Helsinki. : ethical principles for medical research involving human subjects. J Am Coll Dent. 2014;81(3):14\u20138.","journal-title":"J Am Coll Dent"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07711-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-07711-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07711-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:50:17Z","timestamp":1769169017000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-025-07711-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7711"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-07711-5","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the Declaration of Helsinki [\n                      \n                      ]. This human study was approved by the \u201cComit\u00e9 de Protection des Personnes Sud (C.P.P SUD)\u201d - approval: C.P.P SUD N\u00b0351\/2021. All adult participants provided written informed consent to participate in this study. Written informed consent was obtained from the individual(s) (or relative\/guardian) for publication of the details of their medical case and any accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}